PROTAC-15

N/A

Report date: 2021/12/08 13:54:23
NME

Base Information

Drug NamePROTAC-15
Drug Alias NamePROTAC-15PROTAC 15
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionB-cell lymphoma 6 protein inhibitorsProteolysis
TargetsB-cell lymphoma 6 protein
Therapy Area/IndicationsLymphoma, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesYale University
China Registration ClassN/A

Develop Information

Active CompaniesYale University
Inactive CompaniesN/A
Active IndicationsLymphoma, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A